carmellrx.com (CTCX) - Rasio Nilai Pasar marang Nilai Buku

Carmell Corp. (CTCX) - logo korporat

Carmell Corporation (CTCX) is pursuing expansion by scaling regenerative biomaterials. In the price-to-book history illustrated by this GURU.Markets chart, the value -2.81 represents the current metric. Unique plasma products for surgery provide stability, yet business success relies on effective commercialization and strict operational expense control supported by sufficient reserves.

Carmell Therapeutics (CTCX) - Nilai Pasar marang Nilai Buku saka 21.02.2024 nganti 10.03.2025
Produk asil prodhuksi Carmell Corp

Carmell Corporation (CTCX) effectively combines long-term biomedical developments with operational revenue from aesthetic cosmetics. The market-to-book ratio measures the investor premium over the issuer's net assets. This coefficient reflects market confidence in the business's ability to offset cost inflation. A high asset valuation facilitates access to capital despite regulatory risks. The history of the price-to-book ratio clearly demonstrates the dynamics of this balance.

Analisis pesaing

ASND (Ascendis Pharma A/S) - Rasio Kapitalisasi marang Aset Bersih|Rasio Kapitalisasi marang Nilai Buku MDGL|Rasio Nilai Pasar marang Nilai Buku Corcept Therapeutics Incorporated|Rhythm Pharma - Kapitalisasi Pasar marang Aset Bersih|Rasio Kapitalisasi Pasar marang Nilai Buku AKRO|MTSR (Metsera Therapeutics) - Nilai Pasar marang Nilai Buku|Rasio Kapitalisasi Pasar marang Nilai Buku MLTX (MoonLake Immunotherapeutics)|Rasio Kapitalisasi Pasar marang Nilai Buku crinetics.com CRNX|NAMS - Rasio Nilai Pasar marang Nilai Buku|Nilai Pasar marang Nilai Buku SLNO (Soleno Therapeutics Inc)|Amicus Pharma (FOLD) - Rasio Nilai Pasar marang Nilai Buku|Rasio Kapitalisasi marang Aset Bersih 89bio Pharma|AGIO (Agios Pharmaceuticals) - Rasio Kapitalisasi Pasar marang Nilai Buku|Rasio Kapitalisasi Pasar marang Nilai Buku structuretx.com|Rasio Kapitalisasi marang Aset Bersih MDXG (MiMedx)|RZLT (Rezolute Inc) - Nilai Pasar marang Nilai Buku|Rasio Nilai Pasar marang Nilai Buku Lexicon Pharma LXRX|MBX - Rasio Kapitalisasi marang Aset Bersih|Altimmune, Inc. - Rasio Kapitalisasi Pasar marang Nilai Buku|Koefisien Nilai Pasar marang Nilai Buku aardvarktherapeutics.com|SGMT (Sagimet Biosciences Inc.) - Rasio Kapitalisasi marang Aset Bersih|BIOA: Multiplikator Kapitalisasi Pasar marang Nilai Buku|BMEA (Biomea) - Rasio Kapitalisasi Pasar marang Nilai Buku|Rasio Kapitalisasi Pasar marang Nilai Buku Quince|Rasio Kapitalisasi Pasar marang Nilai Buku GUTS|Rasio Nilai Pasar marang Nilai Buku VTVT (vtvtherapeutics.com)|Rasio Nilai Pasar marang Nilai Buku Agape ATP ATPC|Pluristem Therapeutics (PLUR) - Koefisien Nilai Pasar marang Nilai Buku|SYBX - Rasio Nilai Pasar marang Nilai Buku|LPCN: Rasio Nilai Pasar marang Nilai Buku|MTNB: Rasio Kapitalisasi Pasar marang Nilai Buku|SPRB - Kapitalisasi Pasar marang Nilai Buku|Rasio Nilai Pasar marang Nilai Buku Galecto|Lumos Pharma Inc (LUMO) - Kapitalisasi Pasar marang Nilai Buku|Rasio Nilai Pasar marang Nilai Buku Organovo Holdings Inc (ONVO)|Rasio Kapitalisasi marang Aset Bersih Radius Pharmaceuticals RDUS